Correlation Between Praxis Precision and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Elevation Oncology, you can compare the effects of market volatilities on Praxis Precision and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Elevation Oncology.
Diversification Opportunities for Praxis Precision and Elevation Oncology
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Praxis and Elevation is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Praxis Precision i.e., Praxis Precision and Elevation Oncology go up and down completely randomly.
Pair Corralation between Praxis Precision and Elevation Oncology
Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 0.67 times more return on investment than Elevation Oncology. However, Praxis Precision Medicines is 1.48 times less risky than Elevation Oncology. It trades about 0.18 of its potential returns per unit of risk. Elevation Oncology is currently generating about 0.04 per unit of risk. If you would invest 5,825 in Praxis Precision Medicines on August 26, 2024 and sell it today you would earn a total of 1,625 from holding Praxis Precision Medicines or generate 27.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Praxis Precision Medicines vs. Elevation Oncology
Performance |
| Timeline |
| Praxis Precision Med |
| Elevation Oncology |
Praxis Precision and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Praxis Precision and Elevation Oncology
The main advantage of trading using opposite Praxis Precision and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Praxis Precision vs. Molecular Partners AG | Praxis Precision vs. Mineralys Therapeutics, Common | Praxis Precision vs. AN2 Therapeutics | Praxis Precision vs. Pharvaris BV |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |